Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED)
This study has been terminated.
Study NCT00040534   Information provided by Merck Sharp & Dohme Corp.

First Received on June 28, 2002.   Last Updated on February 20, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sponsors listed in this trial